Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

10/21/2019, Monday

Media Contacts:
Kristy Marks
kristy.marks@bausch.com
(908) 927-0683
 

Alli Cloutier
alli.cloutier@zenogroup.com
(212) 299-8956
 

BAUSCH + LOMB INTRODUCES PRESERVISION® AREDS 2 FORMULA MINIGEL EYE VITAMINS

The Only Vitamins that Contain the Exact Nutrient Formula Recommended by the National Eye Institute Now Available in a Smaller-Sized Pill

BRIDGEWATER, N.J., Oct. 21, 2019 – Bausch + Lomb, a leading global eye health company, today announced the U.S. launch of PreserVision® AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currently offered PreserVision AREDS 2 Formula soft gels, offering patients an easier-to-swallow option as compared to the original AREDS 2 soft gels. PreserVision® AREDS 2 Formula minigel eye vitamins contain the exact nutrient formula recommended by the National Eye Institute (NEI) for people with moderate to advanced Age-related Macular Degeneration (AMD) following the landmark AREDS2 clinical study.

“AMD is a leading cause of vision loss in Americans age 50 and older. For my patients who are diagnosed with moderate to advanced AMD, I typically recommend a plan that includes regular exercise, a healthy diet, and PreserVision – a supplement that contains nutrients recommended by the National Eye Institute to help reduce the risk of AMD progression in these patients,” said Rishi Singh, M.D., Cole Eye Institute, Cleveland Clinic. “I am pleased to recommend the new PreserVision AREDS 2 minigels to my patients who have inquired about options that could be easier for them to swallow.”1

It is estimated that as many as 16 million people in the United States have AMD. In its early stages, AMD may not present any symptoms, therefore patients may not think to consult with their eye care professional—leaving opportunity for the condition to advance. Left untreated, AMD has the potential to lead to severe vision loss or blindness.

“We are dedicated to providing eye care professionals and their patients with products that help address their needs,” said Chris Marschall, vice president and general manager, U.S. Consumer Health Care, Bausch + Lomb. “The PreserVision AREDS 2 Formula minigel eye vitamins will provide patients with a new easier-to-swallow1 option that they can incorporate as part of their doctor-recommended plan.”

PreserVision AREDS 2 minigel eye vitamins are available at major retailers nationwide in the vitamin aisle and have a suggested retail price of $32.99 (120-count bottle).

For more information on PreserVision eye vitamins, visit www.preservision.com.

About Bausch + Lomb

Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.  

References
1. Compared to original PreserVision® AREDS 2 soft gels

 

###

 

PreserVision is a trademark of Bausch & Lomb Incorporated or its affiliates.
AREDS2 is a registered trademark of the United States Department of Health and Human Services (HHS).
© 2019 Bausch & Lomb Incorporated or its affiliates.
PVN.0087.USA.19

Print

Number of views (1623)/Comments (0)

x